Trelegy Ellipta for Real Asthma Control Study

Trelegy Ellipta for Real Asthma Control Study - T-RECS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043481

Enrollment

Registered

2021-03-01

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

ICS-LABA-LAMA 100 3 Ms ICS-LABA-LAMA 200 3 Ms

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with asthma symptoms Patients prescribed ICS-LABA or ICS-LAMA

Exclusion criteria

Exclusion criteria: No asthma symptoms Complications with lung cancer or infections Smoking more than 10 pack-yeras

Design outcomes

Primary

Measure	Time frame
FEV1	—

Countries

Japan

Contacts

Public ContactYoshitomo Kushima

Dokkyo Medical University School of Medicine Department of Pulmonary Medicine and Clinical Immunology

kushima@dokkyomed.ac.jp0282872151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026